Clinical Trials Directory

Trials / Completed

CompletedNCT00476671

Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1

Prevalence and Risk Factors of HIV-associated Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1 Infected Thai Individuals With Undetectable Viral Load in the HAART Era.

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
The HIV Netherlands Australia Thailand Research Collaboration · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To assess the prevalence and risk factors of neurocognitive impairment and psychiatric comorbidities in HIV infected patients who have undetectable viral load, have been on HAART for at least 1 year and have no history of CNS infection.

Detailed description

To understand how to prevent and treat HIV-associated neurocognitive impairment and psychiatric comorbidities in HIV-infected Thai individuals who don't have current AIDS related illness or current and prior central nervous system (CNS) infection, and have been well treated with HAART with undetectable HIV RNA.

Conditions

Interventions

TypeNameDescription
PROCEDURElumbar puncture, MRI, MRSlumbar puncture, MRI, MRS are only performed in patients with HIV associated dementia

Timeline

Start date
2007-03-01
Primary completion
2008-04-01
Completion
2008-06-01
First posted
2007-05-22
Last updated
2020-07-17

Locations

1 site across 1 country: Thailand

Source: ClinicalTrials.gov record NCT00476671. Inclusion in this directory is not an endorsement.